Telix Pharmaceuticals Ltd Ordinary Shares

TLX: XASX (AUS)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
N%LOCK|gKZLOCK|bSKk<V

Telix Pharmaceuticals: Paying Up for Vertical Integration and Horizontal Expansion

Telix has agreed to purchase ITM Isotope Technologies, the leading supplier of therapeutic radioisotope lutetium-177, with expansions of two other isotopes in the pipeline. Total consideration is USD 1.65 billion, with 76% in Telix shares priced at USD 11.84 per share, or AUD 16.68.

Sponsor Center